Here are some answers to common questions regarding our new stem cell trial. Our websites will have more information shortly on pages devoted to our stem cell work.
How did the trial get approved?
MSRCNY received approval from the International Cellular Medicine Society (ICMS). This is an Institutional Review Board (IRB) made up of physicians and scientists. They review protocols submitted for phase 1 trials focusing on the use of stem cells. After reviewing our application, ICMS approved our study.
Is there a placebo involved?
No. There is no placebo involved.
I am currently NOT a patient at the International Multiple Sclerosis Management Practice. Can I still participate in the trial?
We are reviewing for enrollment already established patients at the International Multiple Sclerosis Management Practice. For interest in becoming a patient, please look at our website www.imsmp.org and call 212-265-8070. We would welcome all calls and questions to our center, however in all fairness, becoming a patient at our center Does Not guarantee participation in the current stem cell study we are about to begin.
What is the next step in the process and how much does this cost?
The MSRCNY has formed a Stem Cell Research Team to answer your questions about our upcoming study! We are currently working on our information brochure and the patient selection process will be taking place shortly. In addition, MSCRNY has applied for grants and other donations to fund this stem cell trial. The study will be of no profit to IMSMP or MSRCNY. Funding will solely cover the expenses of materials in the laboratory. Please continue to check the website for weekly updates on the progress of this upcoming endeavor!
